Comparable outcomes between immune-tolerant and active phases in noncirrhotic chronic hepatitis B: a meta-analysis.

Han Ah Lee Seung-Up Kim Yeon Seok Seo Sang Hoon Ahn Chai Hong Rim

Published in: Hepatology communications (2023)

The pooled incidence rates of HCC and mortality were comparable between the untreated IT and the treated IA phases in noncirrhotic HBeAg-positive CHB patients.

Keyphrases

hepatitis b virus
end stage renal disease
newly diagnosed
risk factors
ejection fraction
chronic kidney disease
prognostic factors
cardiovascular events
clinical trial
type diabetes
metabolic syndrome
cardiovascular disease
coronary artery disease
adipose tissue
patient reported
insulin resistance
glycemic control